A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept
Clinical trial NCT07419178 · RECRUITING
Trial details
- NCT number
- NCT07419178
- Sponsor
- Azienda Ospedaliero-Universitaria di Parma
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-05
- Primary completion
- 2027-02-28
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.